The oral microbiota in colorectal cancer is distinctive and predictive
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Ireland
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Oral cavity Bucca,Buccal cavity,Cavity of mouth,Oral cavity,oral cavity
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Colorectal cancer cancer of colorectum,cancer of large bowel,cancer of large intestine,cancer of the large bowel,colon cancer,colorectal cancer,colorectum cancer,CRC,large intestine cancer,malignant colorectal neoplasm,malignant colorectal tumor,malignant colorectum neoplasm,malignant large bowel neoplasm,malignant large bowel tumor,malignant large intestine neoplasm,malignant large intestine tumor,malignant neoplasm of colorectum,malignant neoplasm of large bowel,malignant neoplasm of large intestine,malignant neoplasm of the large bowel,malignant neoplasm of the large intestine,malignant tumor of large bowel,malignant tumor of large intestine,malignant tumor of the large bowel,malignant tumor of the large intestine,Colorectal cancer
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy Controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Individuals with CRC
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Individuals diagnosed with CRC
- Group 0 sample size Number of subjects in the control (unexposed) group
- 103
- Group 1 sample size Number of subjects in the case (exposed) group
- 99
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 1 month
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- centered log-ratio
- Statistical test
- ANCOM
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Signature 1
Source: Figure 5(B)
Description: Scatterplot of the colonic prevalence of bacterial OTUs associated with oral pathogen and biofilm CAGs.
Abundance in Group 1: increased abundance in Individuals with CRC
NCBI | Quality Control | Links |
---|---|---|
Dialister | ||
Fusobacterium | ||
Gemella | ||
Parvimonas | ||
Peptostreptococcus | ||
Solobacterium | ||
Streptococcus |
Signature 2
Source: Figure 5(B)
Description: Scatterplot of the colonic prevalence of bacterial OTUs associated with oral pathogen and biofilm CAGs.
Abundance in Group 1: decreased abundance in Individuals with CRC
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Haemophilus | ||
Veillonella |
Experiment 2
Subjects
Lab analysis
Statistical Analysis
Signature 1
Source: supplementary table 2
Description: Differentially abundant taxa in the oral microbiome between colorectal cancer patients and healthy controls by ANCOM
Abundance in Group 1: increased abundance in Individuals with CRC
NCBI | Quality Control | Links |
---|---|---|
Haemophilus | ||
Parvimonas | ||
Prevotella | ||
Alloprevotella | ||
Lachnoanaerobaculum | ||
Neisseria | ||
Streptococcus |
Revision editor(s): Folakunmi
Experiment 3
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Individuals with polyps
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Individuals diagnosed with polyps
- Group 1 sample size Number of subjects in the case (exposed) group
- 32
Lab analysis
Statistical Analysis
Signature 1
Source: supplementary table 2
Description: Differentially abundant taxa in the oral microbiome between colorectal cancer patients and healthy controls by ANCOM
Abundance in Group 1: increased abundance in Individuals with polyps
NCBI | Quality Control | Links |
---|---|---|
Parvimonas | ||
Streptococcus | ||
Leptotrichia |
Revision editor(s): Folakunmi